Clinical trial

Dolutegravir Plus Lamivudine Simplified Therapy

NCT03884673

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2019-01-01

PhaseN/A

Study timeline

Study start (actual)2019-01-01Date precision: day

Registry last updated2022-09-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV/AIDSunresolved

Interventions

Sponsors & collaborators

Guangzhou 8th People's Hospitallead sponsor

Shenzhen Third People's Hospitalcollaborator

Dongguan People's Hospitalcollaborator

Fifth Affiliated Hospital, Sun Yat-Sen Universitycollaborator

The Third People's Hospital of Guilincollaborator

Guangxi Longtan hospitalcollaborator

The Fourth People's Hospital of Nanningcollaborator

The Third People's Hospital of Kunmingcollaborator

Yunnan AIDS Care Centercollaborator

Meng Chao Hepatobiliary Hospital of Fujian Medical Universitycollaborator

First Affiliated Hospital of Guangxi Medical Universitycollaborator

Mapped research locations

GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03884673 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.